gators did not identify which LAT kit was used, but that report (6) suggested that the occurrence of false-negative CSF LAT results is more common than previously appreciated. This report describes false-negative CSF LAT results for three patients with culture-positive cryptococcal meningitis and the investigation of possible causes of this phenomenon.
positive cryptococcal meningitis are reported. False-negative results occurred in settings of low cryptococcal antigen concentrations in cerebrospinal fluid and were dependent on the latex agglutination test kit used. Investigation of each case revealed that prozone phenomena or interference from bound antibody or protein could not account for the false-negative results.
The latex agglutination test (LAT) for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid (CSF) has been established as a reliable and rapid method for diagnosis of Cryptococcus neoformans infections (2, 3, 11, 19) . Four commercial LAT kits, Crypto-LA (International Biological Laboratories, Cranbury, N.J.), MYCO-Immune (American Micro Scan, Mah- wah, N.J.), IMMY (Immuno-mycologics, Norman, Okla.), and CALAS (Meridian Diagnostics Inc., Cincinnati, Ohio), have been widely available for more than 10 years and have been used extensively. Studies evaluating LAT kit performance with CSF samples have reported the sensitivities and specificities summarized in Table 1 . However, there are well-described cases of false-positive LAT results obtained with CSF samples that have been attributed to interfering substances (1) and contamination with syneresis fluid (4, 15) . False-negative CSF LAT results for patients with culturepositive cryptococcal meningitis have been reported to be rare (14) and are not as well characterized. One study reported false-negative CSF LAT results for all specimens from a single patient with culture-positive cryptococcal meningitis that resolved with dilution of the samples, suggesting a prozone phenomenon (20) (alternatively referred to as postzone [12, 21] ). A second study noted a single falsenegative CSF Crypto-LA LAT result that resolved with pronase treatment, even though this treatment is not normally recommended for CSF samples (13) . This suggested the possibility that bound antibody or a nonspecific protein had masked the cryptococcal antigen in this sample (14) . A third study, comparing three of the LAT kits (MYCOImmune, CALAS, and IMMY), reported four false-negative CSF LAT results obtained with culture-positive samples and the IMMY kit that were positive by the two other kits (23) .
The false-negative IMMY CSF LAT results were attributed to less potent anticryptococcal globulin reagents supplied with the IMMY kit (23) . A fourth study reported eight false-negative CSF LAT results for 88 AIDS patients with culture-confirmed cryptococcal meningitis (6) . The investi-* Corresponding author. gators did not identify which LAT kit was used, but that report (6) suggested that the occurrence of false-negative CSF LAT results is more common than previously appreciated. This report describes false-negative CSF LAT results for three patients with culture-positive cryptococcal meningitis and the investigation of possible causes of this phenom- Isolates from each of the three patients were maintained on Sabouraud dextrose agar slants and were confirmed to be C. neofonnans by the ability to hydrolyze urea, a positive bird seed agar response, the ability to grow at 37°C, and analysis with the API 20C system (Analytab Products, Plainview, N.Y.). Each isolate was shown to be C. neoformans var. neoformans by growth on CGB agar (17) . India ink preparations revealed that each isolate had light-tomoderate encapsulation when grown in Sabouraud dextrose broth at 30°C. Genomic DNA was extracted from each isolate and examined by Southern blot analysis of URA5 gene restriction fragment length polymorphisms, as previously described (5) , to investigate the possibility that all three isolates were genetically related. HaeII digestion revealed a different URA5 restriction fragment length poly- morphism pattern for each strain (data not shown). Capsular exopolysaccharide was purified from the culture supernatant of each isolate as previously described (16), and its concentration was determined by the phenol-sulfuric acid method (8) . The purified polysaccharide was serially diluted and tested with all four LAT kits in accordance with the package insert instructions for CSF samples until endpoints for detection were reached. The results are summarized in Table  2 .
Three cases of culture-positive cryptococcal meningitis with false-negative CSF LAT results that occurred in situations with low cryptococcal antigen concentrations in CSF are described. Detection of cryptococcal antigen was dependent on which LAT kit was used. Only the IMMY kit gave positive results for all of the CSF samples from all of the patients. The Crypto-LA and CALAS kits gave consistently negative results for all CSF specimens in which cryptococcal antigen concentrations in CSF were low. The MYCO-Immune kit gave positive results for CSF samples from two of three patients in this setting. None of these false-negative results resolved with dilution of the specimens or with pronase treatment. A similar phenomenon was noted in a study comparing the performance of three LAT kits (IMMY, MYCO-Immune, and Crypto-LA) in which four false-negative CSF LAT results were reported for the IMMY kit but identified as positive with the other two kits (23) . Interestingly, this occurred in a setting of low cryptococcal antigen concentrations in CSF (positive Crypto-LA CSF LAT reported at titers of 1:2 to 1:16 for these specimens). In contrast to the present report, the pattern of false-negative CSF LAT results by kit was different in that study, with the IMMY kit being the least sensitive test.
The initial investigation focused on the characterization of the three C. neoforinans isolates. Since the cases described here came from two hospitals in a limited geographic area, it was possible that a single strain was responsible for the phenomena observed. Restriction fragment length polymorphism analysis showed that each isolate was genetically distinct. It has been suggested that false-negative LAT results could be due to "capsule-deficient" C. neoformans strains (7 (18) . However, it should be noted that low cryptococcal antigen concentrations in CSF can occur in a significant proportion of AIDS patients, as evidenced by the experience of patient 2 and reports in the literature (6, 9) . In evaluating patients with symptoms consistent with cryptococcal infection and negative CSF LAT results, retesting of the CSF with alternative LAT kits may resolve the diagnostic dilemma and avoid treatment delay.
We do not recommend that laboratories switch from one LAT kit to another for routine evaluation of specimens on the basis of the data presented here. We suggest that evaluation of currently available LAT kits, as well as evaluation of new technologies for detection of cryptococcal antigen (such as monoclonal antibody-based LAT kits and enzyme-linked immunoassay systems), include careful evaluation of samples with suspected low antigen concentrations. It is also strongly recommended that for every CSF sample for which a diagnostic LAT is ordered, fungal (and routine) cultures be automatically obtained as well. In addition, CSF fungal cultures should be carefully inspected daily for at least 1 week so that detection of initial growth is not delayed.
